Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma

BACKGROUND: Although the increase in risk of developing breast, ovarian, and prostate cancer in BRCA1 and BRCA2 mutation carriers has been studied extensively, its impact on mortality is not well quantified. Further, possible effect of BRCA mutations on non-cancer mortality risk has not been examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Mai, Phuong L., Chatterjee, Nilanjan, Hartge, Patricia, Tucker, Margaret, Brody, Lawrence, Struewing, Jeffery P., Wacholder, Sholom
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652075/
https://www.ncbi.nlm.nih.gov/pubmed/19277124
http://dx.doi.org/10.1371/journal.pone.0004812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652075/
https://www.ncbi.nlm.nih.gov/pubmed/19277124
http://dx.doi.org/10.1371/journal.pone.0004812

Ejemplares similares